Clinical trial
The Effect of Anticholinesterase Drugs on Sleep in Alzheimer's Disease Patients
NCT00480870 · Associacao Fundo de Incentivo a Psicofarmcologia, Other · Completed
Key facts
| NCT number | NCT00480870 |
|---|---|
| Title | The Effect of Anticholinesterase Drugs on Sleep in Alzheimer's Disease Patients |
| Official title | The Effect of Anticholinesterase Drugs on Sleep in Alzheimer's Disease Patients |
| Acronym | ACHALZSLEEP |
| Lead sponsor | Associacao Fundo de Incentivo a Psicofarmcologia, Other |
| Collaborators | Fundação de Amparo à Pesquisa do Estado de São Paulo |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alzheimer Disease, Sleep Apnea, Obstructive |
| Intervention type | Drug |
| Interventions | donepezil, Placebo |
| Enrollment | 65 |
| Start date | Apr 1, 1999 |
| Completion | Jan 1, 2005 |
| First posted | May 31, 2007 |
| Last update posted | Dec 4, 2007 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: